Oligonucleotides with Non-Natural Bases for HIV Mutation Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The variability of HIV types and rapid mutation of the HIV virus pose challenges for effective detection and treatment, particularly in distinguishing between HIV-1 and HIV-2 strains and identifying drug-resistant mutations, which complicates the development of vaccines and antiretroviral therapies.
Innovation Solution
The use of oligonucleotides with non-natural bases, such as iC and iG, in primer sets for amplifying and detecting specific mutations within the HIV genome, allowing for real-time detection and differentiation of HIV-1 strains and identification of drug-resistant mutations in heterogeneous populations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional oligonucleotide primers are used for HIV detection, then the detection method is simple and cost-effective, but the ability to distinguish between HIV-1 and HIV-2 strains and identify drug-resistant mutations is insufficient due to HIV variability and rapid mutation
Solution Approach 1:
The patent applies local quality by designing primers with non-natural bases (iC and iG) at specific local positions within the oligonucleotide sequence. These modified bases are strategically placed to enhance discrimination between HIV-1 and HIV-2 strains and to detect drug-resistant mutations, while the rest of the primer maintains natural bases for general compatibility. This localized modification resolves the contradiction by improving detection precision without requiring complete redesign of all primers.
Solution Approach 2:
The patent changes the chemical parameter of the oligonucleotide primers by incorporating non-natural bases (iso-cytosine and iso-guanine) that form stable triple-helix structures with specific target sequences. This parameter change enables the primers to differentiate between HIV variants and detect mutations with higher precision, resolving the contradiction between detection accuracy and primer complexity by introducing a new chemical dimension to primer functionality.
2Adaptability or versatility
If multiple primer sets are designed to cover all HIV types and mutations, then detection coverage is improved, but the complexity of the detection system and cost increase
Solution Approach 1:
The patent applies universality by designing a single primer set with non-natural bases that can simultaneously detect multiple HIV types (HIV-1 and HIV-2), various subtypes, and drug-resistant mutations. The primers with iC and iG bases are engineered to recognize conserved regions across different HIV strains while the triple-helix formation provides specificity for mutation detection. This multi-functional primer design resolves the contradiction by achieving broad detection coverage without requiring multiple separate primer sets, thereby reducing system complexity.
3Loss of information
If traditional detection methods are used, then the procedure is straightforward, but real-time detection and differentiation of HIV strains and mutations is not achieved
Solution Approach 1:
The patent introduces non-natural bases (iC and iG) as intermediary elements that mediate between the detection system and the viral genetic information. These intermediary bases form stable triple-helix structures with specific target sequences, enabling real-time detection and differentiation of HIV strains and mutations during the amplification process. This intermediary mechanism resolves the contradiction by capturing viral genetic information in real-time without requiring complex post-amplification analysis procedures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables accurate and efficient detection of HIV mutations, including drug-resistant strains, facilitating appropriate treatment decisions and monitoring of viral load, even in complex genetic backgrounds.
Implementation Method 1
The use of oligonucleotides with non-natural bases, such as iC and iG, in primer sets for amplifying and detecting specific mutations within the HIV genome
Implementation Method 2
amplifying and detecting specific mutations within the HIV genome, allowing for real-time detection and differentiation of HIV-1 strains
Data Source
AI summary
Disclosed are methods and kits for identifying and characterizing polynucleotide sequences in a sample which may include a heterogeneous sample. Some of the methods and kits are directed to the identification and characterization of a virus in a sample, which may include HIV capable of cause AIDS or AIDS-like symptoms. The virus may be HIV-1, and may also include drug resistant mutations. The methods may include reacting a mixture that includes, in addition to nucleic acid isolated from the sample, at least one oligonucleotide capable of specifically hybridizing to HIV nucleic acid where the oligonucleotide includes at least one non-natural base.” fu addition, the methods may include detection of one or more mutations in HIV nucleic acid that are associated with drug resistance.